In a nutshell, the industry of biotechnology focuses on the novel drug development as well as clinical research with the primary focus of treating diseases alongside life-threatening medical conditions. Moreover, biotechnology companies are known for their unprofitable approach with a keen interest in treating patients instead of generating profits. Furthermore, biotechnology companies are characterized by the series of development lead times that can take up to a decade to find solutions.
Jeff Aronin Takes the Risk
As a result, most health entrepreneurs shy away from betting on such companies. However, Jeff Aronin is one successful entrepreneur who decided to take the chance and delve into the investment of biotechnology. As such, he established Paragon Biosciences with the intention of working hand-in-hand with scientific researchers to develop a robust research platform for biotechnology companies.
What is Paragon Biosciences?
Paragon Biosciences is a prominent incubator as well as an investment company that grows leading biotechnology firms. Moreover, the company helps people to lead longer, as well as healthier lives free from diseases that are difficult to cure.
How Does Paragon Biosciences Work?
Paragon Biosciences works through a reliable technology platform that builds a stable platform for companies by bringing vital medicines to patients. Moreover, the portfolio of the company has companies that are dedicated to managed healthcare and are all too often, industry leaders in their own way.
How Jeff Aronin is Affiliated with Paragon Biosciences
Behind the Paragon’s success in investing in healthcare companies is one Jeff Aronin who has taken effective and instrumental measures in investing in such companies. What began in a small operating room where he was tasked with the responsibility of watching over a patient vastly transformed into a company that invests in the healthcare sector. Therefore, currently, Jeff Aronin has always been trusted with the responsibility of helping people who suffer from various diseases access better treatment options.
Aronin uses a unique business model that provides financial as well as strategic assistance to biotechnology firms that strive to generate new, revolutionary medicines. Moreover, Aronin guides Paragon’s management through establishing in-depth research to accelerate breakthrough science and build companies by alleviating suffering from patients.